GPT Healthcare Ltd

GPT Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 22 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

GPT Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 11 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

GPT Healthcare Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive grade, reflecting evolving investor sentiment amid a challenging market backdrop. Despite a micro-cap status and a recent downgrade in its Mojo Grade to Sell, the hospital sector stock presents compelling valuation metrics relative to peers and historical averages, warranting a closer examination of its price attractiveness and investment potential.

GPT Healthcare Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend as of early April 2026. Despite a positive day change of 2.68%, the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the recent price action, key technical indicators such as MACD, RSI, moving averages, and broader market comparisons to provide a comprehensive view of the stock’s current positioning.

GPT Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 31 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Despite broader market resilience, GPT Healthcare Ltd has succumbed to continued selling pressure, hitting a fresh all-time low of Rs.114 on 30 Mar 2026. The stock’s recent decline extends a losing streak that has seen it underperform its sector and benchmark indices significantly over multiple time frames.

While the broader market shows signs of recovery, GPT Healthcare Ltd has succumbed to persistent selling pressure, hitting a fresh 52-week low of Rs 114 on 30 Mar 2026. This decline contrasts sharply with the Sensex’s modest gains over the past three days, underscoring stock-specific challenges that continue to weigh on the hospital sector micro-cap.

GPT Healthcare Ltd’s share price declined to an all-time low of Rs.117.5 on 27 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock underperformed both its sector and the broader market, reflecting persistent challenges in its financial performance and market sentiment.

Despite a broader market rally, GPT Healthcare Ltd has plunged to a fresh 52-week low of Rs 117.6 on 27 Mar 2026, marking a significant divergence from the overall market trend and underscoring persistent headwinds for the micro-cap hospital sector player.

While broader indices like the Sensex have been attempting to stabilise, GPT Healthcare Ltd has continued its downward trajectory, hitting a fresh 52-week low of Rs 117.9 on 23 Mar 2026. This decline comes amid a three-day losing streak that has erased 4.71% of the stock’s value, underscoring persistent headwinds for the hospital sector micro-cap.

Despite a broadly positive market environment, GPT Healthcare Ltd has succumbed to a three-day losing streak, culminating in a fresh all-time low of Rs.117.9 on 23 Mar 2026. The stock’s decline contrasts sharply with the sector’s 3.36% fall and the Sensex’s 2.39% drop on the same day, underscoring a pronounced stock-specific weakness.

GPT Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

GPT Healthcare Ltd’s shares declined sharply to a new 52-week low of Rs.118.2 on 9 Mar 2026, marking a significant downturn amid broader market weakness and company-specific headwinds. The stock underperformed its sector and key indices, reflecting ongoing concerns about its financial performance and investor sentiment.

GPT Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

GPT Healthcare Ltd’s shares declined to a fresh all-time low of Rs.118.2 on 9 Mar 2026, marking a significant milestone in the stock’s extended downward trajectory. The hospital sector stock has underperformed both its sector peers and the broader market indices over multiple time frames, reflecting persistent pressures on its financial performance and investor sentiment.